The cover picture shows the new metal–organic frameworks (MOFs) ZJU-64 and ZJU-64-CH
3, which exhibit low totoxicity, high stability, and temperature-controlled
drug-release behaviors. The findings provide a strategy to enhance the therapeutic efficacy of these MOFs because of their capacity for combining
drug and thermal therapies. More details can be found in the Full Paper by
Guodong Qian and co-workers on
page 804 in Issue 8, 2016 (DOI:
10.1002/cplu.201600142).